Nobel Biocare Holding AG (XSWX:NOBN) Selling, General, & Admin. Expense : CHF365.0 Mil (TTM As of Dec. 2013)

Nobel Biocare Holding AG Selling, General, & Admin. Expense Chart

Nobel Biocare Holding AG Annual Data
	Trend	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Selling, General, & Admin. Expense		Get a 7-Day Free Trial					472.00	424.76	406.98	376.40	365.01

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
Selling, General, & Admin. Expense	Get a 7-Day Free Trial							472.00	424.76	406.98	376.40	365.01

Competitive Comparison of Nobel Biocare Holding AG's Selling, General, & Admin. Expense

For the Medical Instruments & Supplies subindustry, Nobel Biocare Holding AG's Selling, General, & Admin. Expense, along with its competitors' market caps and Selling, General, & Admin. Expense data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Nobel Biocare Holding AG's Selling, General, & Admin. Expense Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nobel Biocare Holding AG's Selling, General, & Admin. Expense distribution charts can be found below:

* The bar in red indicates where Nobel Biocare Holding AG's Selling, General, & Admin. Expense falls into.

Nobel Biocare Holding AG Selling, General, & Admin. Expense Calculation

Selling, General, & Admin. Expense (SGA) includes the direct and indirect costs and all general and administrative expenses of a company. For instance, personnel cost, advertising, rent, communication costs are all part of SGA.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Selling, General, & Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2013 was CHF365.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nobel Biocare Holding AG  (XSWX:NOBN) Selling, General, & Admin. Expense Explanation

An efficient operation keeps SGA costs low and thus has higher profit margin. The percentage of SGA relative to total revenue is an indication of how efficiently the company operates. Compare this percentage among the companies in the same industry is a good way of finding more efficient operations. A comparison of the SGA cost relative to the revenue with the historical value can also be an indication of how efficient the company has become.

Warren Buffett likes companies with consistent SGA as the percentage of gross profit.

Companies with no durable competitive advantage show wild variation in SG&A as % of Gross Profit.

If SGA is less than 30% of Gross Profit, it is fantastic. If SGA is nearing 100%, it is is in highly competitive industry.

Nobel Biocare Holding AG Selling, General, & Admin. Expense Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's Selling, General, & Admin. Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (XSWX:NOBN) Business Description